Skip to main content
    S

    Senti Biosciences Inc (SNTI)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $0.10
    -0.04 (-28.68%)

    Market Cap: $5.38M

    Last updated: Nov 17, 2026 at 4:44 PM ET

    Senti Biosciences Inc (SNTI) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Senti Biosciences (SNTI) has a market cap of $5.38M and an enterprise value of $6.13M. It kept -58140.54% of revenue as net income over the last 12 months. Revenue fell 98.74% over the last 12 months from the 12 months before.

    Total Valuation

    Enterprise value is 13.82% above the market cap, as debt exceeds cash.

    Market Cap$5.38M
    Enterprise Value$6.13M
    Latest price (Nov 17, 2026)$0.10

    Key Dates

    The next earnings report is expected on Mar 22, 2027, covering the quarter ending Dec 31, 2026.

    Next Earnings DateMar 22, 2027 (expected)
    Last Earnings DateAug 14, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count held steady in the quarter ended Sep 30, 2026 and grew 160.85% a year over 2 years.

    Shares Outstanding31.15M
    Shares Change (YoY)+18.75%
    Shares Change (QoQ)0.00%
    Share Count Growth (2Y CAGR)+160.85%

    Valuation Ratios

    The price to sales ratio is 40.8x.

    P/S Ratio40.8x
    Forward P/S107.7x

    Price Statistics

    The stock is down 93.98% over 52 weeks and trades 60.00% below its 50-day average.

    Beta (1Y)2.48
    52-Week Change-93.98%
    1-Month Change-57.23%
    3-Month Change-79.05%
    6-Month Change-88.98%
    5-Year Change-99.84%
    Total Return (1Y)-93.98%
    Total Return (3Y CAGR)-71.11%
    Total Return (5Y CAGR)-75.06%
    Max Drawdown (1Y)-95.94%
    Max Drawdown (3Y)-99.03%
    Sharpe Ratio (1Y)-2.46
    Correlation with SPY (1Y)0.29
    50-Day Average$0.25
    200-Day Average$0.67
    52-Week Range$0.13 to $2.48
    RSI (14 Days)25.1
    Average Volume (20 Days)8.84M

    The 5-year change compares month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 0.54x current liabilities.

    Current Ratio0.54x
    Quick Ratio0.54x

    Returns and Efficiency

    Return on invested capital is 1039.76% over the last 12 months.

    Return on Assets (ROA)-151.71%
    Return on Invested Capital (ROIC)1039.76%
    ROA (5Y Average)-64.55%
    Asset Turnover0.00x
    Receivables Turnover0.11x

    Scores

    SNTI has an Altman Z-Score of -24.47, in the distress zone below 1.81, and a Piotroski F-Score of 1 of 9, in the weak band of 0 to 2.

    Altman Z-Score-24.47
    Altman Z ZoneDistress
    Piotroski F-Score1 of 9
    Piotroski StrengthWeak

    Income Statement

    Revenue was $74.00K over the last 12 months.

    Revenue$74.00K
    Revenue Growth (YoY)-98.74%
    Gross Profit$74.00K
    Operating Income-$50.06M
    Pretax Income-$43.23M
    Net Income-$43.02M
    EBITDA-$40.63M
    Reported EPS (TTM)-$1.77

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Cash and Equivalents$5.55M
    Total Debt$6.30M
    Net Debt$744.00K
    Net Debt Per Share$0.02
    Working Capital-$8.07M
    Shareholder Equity-$9.60M
    Total Assets$28.36M
    Total Liabilities$37.96M

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    Operating Cash Flow-$35.33M
    FCF Per Share-$0.92
    Depreciation and Amortization$2.90M

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is -67652.70%.

    Gross Margin100.00%
    Operating Margin-67652.70%
    Pretax Margin-58417.57%
    Net Margin-58140.54%
    EBITDA Margin-54901.35%

    Growth

    Revenue fell 82.75% a year over 3 years.

    Revenue Growth (3Y CAGR)-82.75%
    Revenue Growth (5Y CAGR)-43.85%
    Book Value Per Share Growth (2Y CAGR)-59.27%
    Tangible Book Per Share Growth (2Y CAGR)-59.27%

    Revenue and profit by year

    Dividends and Yields

    SNTI does not pay a dividend.

    Buyback Yield-347.06%
    Shareholder Yield-347.06%

    Stock Splits

    The last split was a 1-for-10 reverse split on Jul 18, 2024.

    Last Split DateJul 18, 2024
    Split TypeReverse split
    Split Ratio1:10

    Peer Position

    Against 5 similar companies, SNTI has the highest ROIC.

    ROIC1039.76% vs -150.11% median
    Revenue Growth (Trailing 4 Quarters, YoY)-98.74% vs -100.00% median

    Competitors compared

    Analyst Forecast

    Consensus estimates put revenue growth at 50.76% a year over the next 2 fiscal years.

    Revenue Growth Forecast (2Y CAGR)+50.76%

    Analyst estimates by year

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Frequently Asked Questions About SNTI

    What is SNTI's market cap?

    Senti Biosciences has a market cap of $5.38M. Its enterprise value, which adds debt and subtracts cash, is $6.13M.

    How many shares of SNTI are outstanding?

    Senti Biosciences has 31.15M shares outstanding. The count is up 18.75% from a year earlier.

    Does SNTI pay a dividend?

    No. Senti Biosciences does not pay a dividend.

    How much debt does SNTI have?

    Senti Biosciences has $6.30M of total debt and $5.55M of cash and equivalents, a net debt position of $744.00K.